Value of dual-time-point 18FDG PET-CT imaging on involved-field radiotherapy for hilar and mediastinal metastatic lymph nodes in non-small cell lung cancer

( views:176, downloads:0 )
Author:
HU Man(Department of Radiation Oncology,Shandong Tumor Hospital,Jinan 250017,China)
SUN Xin-dong(Department of Radiation Oncology,Shandong Tumor Hospital,Jinan 250017,China)
LIU Ning-bo(Department of Radiation Oncology,Shandong Tumor Hospital,Jinan 250017,China)
GONG He-yi(Department of Radiation Oncology,Shandong Tumor Hospital,Jinan 250017,China)
Fu Zheng()
MA Li()
LI Xin-ke(Department of Radiation Oncology,Shandong Tumor Hospital,Jinan 250017,China)
XU Xiao-qing(Department of Radiation Oncology,Shandong Tumor Hospital,Jinan 250017,China)
YU Jin-ming(Department of Radiation Oncology,Shandong Tumor Hospital,Jinan 250017,China)
Journal Title:
CHINESE JOURNAL OF RADIATION ONCOLOGY
Issue:
Volume 17, Issue 04, 2008
DOI:
Key Word:
Lung neoplasms,lymph metastasis/radiotherapy;18F-deoxyglucose;Tomography,emission computed;Dual-time-point imaging

Abstract: Objective To discuss the value of dual-time-point 18FDG PET-CT imaging on involved field radiotherapy for hilar and mediastinal metastatic lymph nodes in patients with non-small cell lung cancer (NSCLC).Methods Fifty-four patients with NSCLC were included in this analysis,including 34 men and 20 women with mean age of 59(34-76)years.Two sequential PET-CT scans given 3-5 days before surgery were standard single-time-point imaging for the whole body and delayed imaging for the thorax.The pathologic data were used as golden standard to determine the difference between the standard single-time-point and dual-time-point FET-CT imaging in the definition of gross target volume(GTV)of involved-field radiotherapy for metastatic lymph nodes. Results For hilar metastatic lymph nodes,the GTV defined by single-time-point imaging was consistent with pathologic GTV in 21 patients(39%),comparing with 31 patients(57%) by dual-time-point imaging.Using pathologic data as golden standard,GTV alteration defined by single-time-point imaging had statisticaly significant difference comparing with that defined by dual-time-point imaging(u=519.00,P=0.023).For mediastinal metastatic lymph nodes,the GTV defined by single-time-point imaging was consistent with pathologic GTV in 30 patients(56%),comparing with 36 patients(67%)by dual-time-point imaging.Using pathologic data as golden standard.GTV alteration defined by single-time-point imaging had no statisticaly significant difference comparing with that defined by dual-time-point imaging(u=397.50,P=0.616).Conclusions For patients with NSCLC receiving involved-field radiotherapy,GTV definition for hilar and mediastinal metastatic lymph nodes by dual-time-point imaging is more consistent with that by pathologic data.Dual-time-point imaging has a larger value in terms of target delineation for hilar and mediastinal metastatic lymph nodes.

  • [1]Bryant AS,Cerfolio RJ,Klemm KM,et al.Maximum standard uptake value of mediastinal lymph nodes on integrated FDG-PET-CT predicts pathology in patients with non-small cell lung cancer.Ann Thorac Surg,2006,82:417-422.
  • [2]Ma SY,See LC,Lai CH,et al.Delayed(18)F-FDG PETfor detection of paraaortie lymph node metastases in cervical cancer patients.J Nucl Med,2003,44:1775-1783.
  • [3]Xiu Y,Bhutani C,Dhurairaj T,et al.Dual-time point FDG PET imaging in the evaluation of pulmonary nodules with minimally increased metabolic activity,Clin Nucl Med,2007,32:101-105.
  • [4]于金明.二十一世纪的放射肿瘤学.中华肿瘤杂志,2002,24:521-525.
  • [5]Yuan S,Sun X,Li M,et al.A randomized study of involved-field irradiation VS.elective nodal irradiation in combination with concurrent chemotherapy for inoperable stage Ⅱ non-small cell lung cancer.Am J Clin Oncol,2007,30:1-6.
  • [6]Belderbos JS,Heemsbergen WD,De Jaeger K,et al.Final results of a Phase Ⅰ/Ⅱ dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy.Int J Radiat Oncol Biol Phys,2006,66:126-134.
  • [7]于金明,孙新东.局部晚期非小细胞肺癌累及野照射的研究进展.中华放射肿瘤学杂志,2005,14:338-341.
  • [8]Fritscher RA,Bohuslavizki KH,Bran&L,et al.Mediastinal lymph node involvement in potentially respectable lung cancer:eomparison of CT,positron emission tomography,and endoscopic ultrasonography with and without fine-needl easpiration.Chest,2003,123:442-451.
  • [9]Yasufuku K,Nakajima T,Motoori K,et al.Comparison of endobronchial ultrasound,positron emission tomography,and CT for lymph node staging of lung cancer.Chest,2006,130:710-718.
  • [10]李万龙,于金明,范廷勇.氟脱氧葡萄糖PET-CT对非小细胞肺癌纵隔淋巴结转移的诊断价值.中华放射肿瘤学杂志,2005.14:166-168.
  • [11]Yuan S,Yu Y,Chao KS,et al.Additional value of PET/CT over PET in assessment of loeoregional lymph nodes in thoracic esophageal squamous cell cancer.J Nucl Med,2006,47:1255-1259.
  • [12]刘兰平,于金明,郭洪波,等.18F-FDG PET-CT确定非小细胞肺癌靶区的初步探讨.中华肿瘤杂志,2007,29:453-456.
  • [13]郭洪波,于金明,张百江,等.氟脱氧葡萄糖PET-CT确定食管癌淋巴结放疗靶区的可行性研究.中华放射肿瘤学杂志,2007,16:10-13.
  • [14]Houseni M,Chamroonrat W,Bural G,et al.Pattern of the tumor metabolism differs between the primary cancer of the lung and the metastatic lymph nodes as determined by FDG-PET dual-time-point imaging.J Nucl Med,2006,47 Suppl:427.
  • [15]Alavi A,Gupta N,Alberini JL,et al.Positron emission tomography imaging in nonmalignant thoracic disorders.Semin Nucl Med,2002,32:293-321.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn